Business

Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces that during the PAINWeek conference 2025, it will showcase a poster outlining key data on LPT-CBD pharmacokinetics and efficacy along with the recently published narrative review titled "Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review" (DOI: https://doi.org/10.7759/cureus.81577). PAINWeek

articleInnocan Pharma CorporationAugust 22, 20255/company/innocan-pharma-corporation/news/innocans-findings-showcased-scientific-poster-200000047
Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada

About this update from Innocan Pharma Corporation

[{"type":"list","items":[{"val":[{"type":"text","content":"PAINWeek is the premier US conference in pain management  ","length":57,"tagName":"p"}]},{"val":[{"type":"text","content":"Innocan's Poster "Is Long-Acting Synthetic Cannabidiol a Solution to Chronic Pain?" to be highlighted ","length":120,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":177,"olType":false},{"type":"text","content":"HERZLIYA, Israel and CALGARY, AB, Aug. 22, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces that during the PAINWeek conference 2025, it will showcase a poster outlining key data on LPT-CBD pharmacokinetics and efficacy along with the recently published  narrative review titled "Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review" (DOI: https://doi.org/10.7759/cureus.81577).  PAINWeek is the premier US national conference on pain management, taking place this year in Las Vegas, Nevada, from September 2–5, 2025. The poster will be showcased during the scientific poster reception on September 4 (Poster #29), presented by Joseph V. Pergolizzi, Jr., MD, MBA, NEMA Research, a key member of Innocan's advisory board.","length":939,"tagName":"p"},{"type":"image","alt":"Figure 1","displaySize":"","headline":null,"caption":"Figure 1","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":194,"url":"https://media.zenfs.com/en/cnwgroup.com/55385202aebc823ab514b2acbed3f289"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/5VxrFH_JsHmtS3sKPnF2EQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM0MjtjZj13ZWJw/https://media.zenfs.com/en/cnwgroup.com/55385202aebc823ab514b2acbed3f289","width":400,"height":194}},"href":"https://mma.prnewswire.com/media/2756141/Figure_1.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Figure 1Photo - https://mma.prnewswire.com/media/2756141/Figure_1.jpg","length":70,"tagName":"p"},{"type":"text","content":"To arrange a meeting with Innocan during PAINWeek please e-mail: [email protected]","length":87,"tagName":"p"},{"type":"text","content":"PAINWeek is a prestigious event that brings together leading clinicians, researchers, and educators in the field of pai...

More updates from Innocan Pharma Corporation

Innocan Pharma Corporationpain managementopioid dependencyLPT-CBDInnocan